Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ST-605 Phase 2 Study in Cytomegalovirus Corneal Endotheliitis
jRCT2080223131Phase 2
- Sponsor
- M's Science Corporation
- Start
- Mar 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ganciclovir, sponsored by M's Science Corporation.
02
Drugs
ganciclovir
Beyond the preview
Go deeper on jRCT2080223131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223131.